According to a study in CHEST, patients with COPD showed decreased gray matter volume in parts of the brain involved in the processing of dyspnea, fear, and antinociception.
Low circulating concentrations of the anti-inflammatory protein CC16 is a predictor for accelerated lung function decline and incident COPD in adults.
In a recent year-long study, 40% of patients with COPD experienced falls, with more than 75% of these patients falling multiple times.
Propeller Health has received US FDA 510(k) clearance to market its Propeller platform in association with medications using GlaxoSmithKline’s Diskus dry powder inhaler.
AstraZeneca and Kyowa Hakko Kirin have entered into an agreement for an exclusive option to commercialize the antibody benralizumab for the treatment of asthma and COPD in Japan.
A new study found COPD patients aged 65 to 85 benefitted from regularly practicing liuzijue qigong, a routine of meditative movement and breathing patterns traditionally performed in China.
Household air pollution (HAP) secondary to indoor combustion of solid fuel may be the biggest risk factor for COPD globally, according to a study published on Medscape.
A new study suggests that poorer lung function in early adulthood may be enough to predispose a person to COPD later in life.
A new 2-year trial by Oxford University will examine if regular IV injections of iron could improve symptoms in individuals with chronic lung diseases.
A New England Journal of Medicine study indicates that passive smoking as a child or teen may increase the risk of developing COPD later in life.
Research from the University of Copenhagen reveals that accelerated decline of lung function may not be a prerequisite for COPD.
The clinical biomarker plasma fibrinogen has been granted approval for use in interventional clinical tests, which makes it the first COPD biomarker to receive FDA approval.
Depression, fatigue and vigilance play a role in shaping brain mechanisms associated with interpretation of dyspnea-related cues in patients with COPD.
RT-led care combined with use of noninvasive positive pressure ventilation via the Philips Respironics Trilogy 100 ventilator successfully reduced COPD readmissions during a 12-month period by 97%.
Aspiration pneumonia is associated with a higher in-hospital mortality rate than community-acquired pneumonia in patients with COPD.
Early introduction of A1P1 protein augmentation therapy to patients with emphysema may be beneficial in the treatment of the condition.
The use of medical imaging can provide vital information tailored to the symptoms and exercise capabilities of patients with COPD, according to a study.
A Johns Hopkins University study revealed that cooler temperatures may benefit COPD patients while warmer temperatures may result in negative health issues.
A group of researchers is questioning the potential effect of a new algorithm proposed for the management of patients with COPD.
An analysis published in the BMJ says current GOLD guidelines for COPD don't work and calls for the adoption of lower limits of normal (LLN) criteria for airflow obstruction that are specific for different populations.